Some scientists are skeptical of the entourage effect in psychedelics as research companies are charging ahead with the concept.
Patent filings indicate that CaaMTech was the first company to propose an entourage effect in psychedelic compounds.
This company is approaching psychedelic mushroom research literally from the ground up.
“I believe one person can produce enough 5-MeO-DMT to supply everyone that would ever want it.”
“Our researchers will isolate and study all of the potentially ‘magic’ molecules in mushrooms.”
The entourage effect caught PSR’s eye back in early 2019. What are experts saying about the theory now and how are psychedelic research companies approaching it?
This is the first time since the 1970s that a Canadian company has legally cultivated and harvested psychedelic mushrooms.
The research will use cutting-edge technology to attempt to remove undesirable side-effects from drugs targeting GPCRs, including the serotonin receptors where psychedelics act.
This collaboration will determine the full scope of the pharmacological effects of several synthetic tryptamine compounds.
This technology developed by MindMed and Liechti Lab may help ease some of the concerns surrounding psychedelic therapy.